Selected Document Category: | Published Document |
Source: | Nanotechnology Characterization Laboratory |
Anticipated Publication Year: | |
Publication Year: | 2011 |
Acronym: | NCL |
Identifier: | ITA-17 |
Document Title: | In Vitro Induction of Leukoc yte Procoagulant Activity by Nanoparticles |
url: | http://ncl.cancer.gov/NCL_Method_ITA-17.pdf |
Scope: | Leukocyte procoagulant activity (PCA) is accepted as an important component in the onset of disseminated intravascular coagulation (DIC). DIC is common in acute promyelocytic leukemia (APL) and other forms of cancer 1-5. DIC in cancer patients is often observed afterinitiation of therapy with cytotoxic oncology drugs that act by altering DNA replication (e.g.,doxorubicin, daunorubicin, and vincristin)3, 6. |
Keywords: | PCA, DIC, APL |
Type of Document: | e. Specification |
Issues Areas: | Measurement and Characterizations Health, Safety, and Environment |
Primary Category: | Chemicals e.g. pesticides, pharmaceuticals, paints, basic chemicals |
Additional Categories | |
Goal or Need: | |
Intended Stakeholders: | |
Is it Being Implemented: | |
Submitter's Name: | Admin |
Submitter's e-mail: | [email protected] |
Submitter's Company: | ANSI |
Additional Comments: | |
Contact for Additional Info: | http://ncl.cancer.gov/working_assay-cascade_download.asp |